Previous article Next article

The Russian Competition Authority confirms that the pharmaceutical company with dominant position in wholesale of certain generics ceased problematic behavior and signed a contract for medicine supply (Ipsen / Biotek)

Ipsen Company Comply With the Warning of the FAS Russia* Pharmaceutical company made required amendments to the Commercial policy and signed a contract with a distributor to supply their products FAS Russia received a

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Russian Competition Authority, The Russian Competition Authority confirms that the pharmaceutical company with dominant position in wholesale of certain generics ceased problematic behavior and signed a contract for medicine supply (Ipsen / Biotek), 9 November 2020, e-Competitions Preview, Art. N° 97866

Visites 66

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues